BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu B, Xu C, Feng J, Chen J, Rui Y, Qiu Z, Zhu J, Tang J, Lou H, Chen T, Ge H, Ge X, Wang Z, Huang H, Pan M, Dai Y, Hu Y, Zhou YH. Reduced mother-to-child transmission of hepatitis B after implementation of completely charge-free active-passive immunoprophylaxis: an observational cohort study. Expert Rev Vaccines 2021;20:899-905. [PMID: 33960275 DOI: 10.1080/14760584.2021.1927723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang S, Wang C, Liu B, Lu Q, Shang J, Zhou Y, Jia J, Xu X, Rao H, Han B, Zhao T, Chen L, Xie M, Cui J, Du J, zeng J, huang N, Liu Y, Zhang L, Zhuang H, Cui F. Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation. The Lancet Regional Health - Western Pacific 2023. [DOI: 10.1016/j.lanwpc.2023.100738] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhang W, Xu C, Rui Y, Chen J, Chen T, Dai Y, Xu B, Hu Y, Chen J, Zhou Y. Efficacy of the hepatitis B vaccine alone in the prevention of hepatitis B perinatal transmission in infants born to hepatitis B e antigen-negative carrier mothers. Journal of Virus Eradication 2022. [DOI: 10.1016/j.jve.2022.100076] [Reference Citation Analysis]
3 Huang H, Zhang X, Luo Y, Chen J, Feng J, Dai Y, Hu Y, Zhou YH. The optimal interval for post-vaccination serological test in infants born to mothers with positive hepatitis B surface antigen. Hum Vaccin Immunother 2021;:1-5. [PMID: 34736352 DOI: 10.1080/21645515.2021.1992213] [Reference Citation Analysis]